Target intelligence / Profile preview

Zinc finger protein multitype 1 (ZFPM1) (ZFPM1)

Target
ZFPM1
Molecular classification
Transcription factor, Zinc finger protein, Transcription coregulator
01

Overview

Zinc finger protein multitype 1 (ZFPM1), commonly referred to as Friend of GATA protein 1 (FOG-1), is a multi-zinc finger transcription coregulator that is indispensable for normal hematopoiesis [1, 2]. It acts as a primary cofactor for GATA family transcription factors, most notably GATA-1, by mediating the recruitment of the Nucleosome Remodeling and Deacetylase (NuRD) complex to target genes [3, 9]. This interaction is essential for the 'GATA switch' and the subsequent differentiation of erythroid and megakaryocytic cells [31, 32]. Genetic mutations that abrogate the GATA-1/FOG-1 interaction are clinically linked to severe conditions such as X-linked thrombocytopenia and dyserythropoietic anemia [13, 16]. Additionally, FOG-1 has been implicated in cardiac development and the suppression of Th2-mediated immune responses, suggesting its potential as a therapeutic target for allergic diseases [6, 21]. Although there are currently no approved pharmacological agents that directly target FOG-1, research has identified compounds like wogonin that can enhance its binding to GATA-1, and triptolide has been identified as an upstream regulator of its expression [5, 28]. The protein's central role in lineage commitment and its involvement in hematological malignancies like acute megakaryoblastic leukemia make it a high-priority subject for the development of novel transcription factor-directed therapies [17, 35].

Other names
Friend of GATA protein 1FOG-1FOG1Zinc finger protein, FOG family member 1ZNF89AZC2HC11AZNF408Zinc finger protein multitype 1
02

Mechanism of action

Acts as a cofactor for GATA transcription factors (GATA1, GATA2, GATA3) and recruits the NuRD (Nucleosome Remodeling and Deacetylase) complex to regulate gene expression.

03

Biological functions

ErythropoiesisMegakaryopoiesisPlatelet formationGene expression regulationTh1/Th2 differentiationCardiac developmentGonadal development
04

Disease associations

ThrombocytopeniaBeta-thalassemiaAnemiaLeukemiaAllergic diseaseTesticular germ cell tumor
05

Safety considerations

Hematological toxicity (anemia, thrombocytopenia)Potential developmental defects (cardiac, gonadal)
06

Interacting drugs

Wogonin

1 more in the full profile.

07

Biomarkers

ZFPM1 expression levelsGATA1/FOG1 interaction statusZFPM1 mutations

Beyond the preview

Go deeper on Zinc finger protein multitype 1 (ZFPM1) (ZFPM1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein multitype 1 (ZFPM1) (ZFPM1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call